Romana Hochreiter

1.5k total citations · 1 hit paper
33 papers, 873 citations indexed

About

Romana Hochreiter is a scholar working on Infectious Diseases, Public Health, Environmental and Occupational Health and Parasitology. According to data from OpenAlex, Romana Hochreiter has authored 33 papers receiving a total of 873 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 13 papers in Public Health, Environmental and Occupational Health and 7 papers in Parasitology. Recurrent topics in Romana Hochreiter's work include Viral Infections and Vectors (14 papers), Mosquito-borne diseases and control (11 papers) and Vector-borne infectious diseases (7 papers). Romana Hochreiter is often cited by papers focused on Viral Infections and Vectors (14 papers), Mosquito-borne diseases and control (11 papers) and Vector-borne infectious diseases (7 papers). Romana Hochreiter collaborates with scholars based in Austria, United States and France. Romana Hochreiter's co-authors include Josef Thalhamer, Katrin Dubischar, Arnulf Hartl, Nina Wressnigg, Susanne Eder-Lingelbach, Fátima Ferreira, Kerstin Westritschnig, Bernd Jilma, Christa Firbas and Martina Schneider and has published in prestigious journals such as The Lancet, Analytical Biochemistry and The Lancet Infectious Diseases.

In The Last Decade

Romana Hochreiter

32 papers receiving 847 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial

2023 94 citations Martina Schneider, Robert P. McMahon et al. The Lancet profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Romana Hochreiter Austria	17	367	291	180	146	138	33	873
Thor Bech Johannesen Denmark	16	473 1.3×	76 0.3×	65 0.4×	139 1.0×	365 2.6×	31	976
Annette Dougall Australia	13	315 0.9×	209 0.7×	24 0.1×	164 1.1×	151 1.1×	13	845
Magali Garcia France	16	197 0.5×	85 0.3×	33 0.2×	101 0.7×	142 1.0×	41	702
Zemira Samra Israel	15	103 0.3×	123 0.4×	65 0.4×	125 0.9×	96 0.7×	34	529
Achim Hoerauf Germany	12	687 1.9×	121 0.4×	19 0.1×	226 1.5×	152 1.1×	17	1.2k
Warren V. Kalina United States	14	533 1.5×	54 0.2×	44 0.2×	508 3.5×	223 1.6×	25	1.2k
Joana Revez Finland	16	262 0.7×	33 0.1×	39 0.2×	58 0.4×	130 0.9×	35	762
Darwin J. Operario United States	21	443 1.2×	135 0.5×	10 0.1×	212 1.5×	187 1.4×	32	940
Émilie Fréalle France	20	519 1.4×	25 0.1×	27 0.1×	395 2.7×	236 1.7×	52	1.1k
Sílvia Maria Lucena Montenegro Brazil	18	158 0.4×	284 1.0×	12 0.1×	150 1.0×	108 0.8×	55	858

Countries citing papers authored by Romana Hochreiter

Since Specialization

Citations

This map shows the geographic impact of Romana Hochreiter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Romana Hochreiter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Romana Hochreiter more than expected).

Fields of papers citing papers by Romana Hochreiter

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Romana Hochreiter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Romana Hochreiter. The network helps show where Romana Hochreiter may publish in the future.

Co-authorship network of co-authors of Romana Hochreiter

This figure shows the co-authorship network connecting the top 25 collaborators of Romana Hochreiter. A scholar is included among the top collaborators of Romana Hochreiter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Romana Hochreiter. Romana Hochreiter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wagner, Laura Danielle, Romana Hochreiter, Santhosh Kumar Ghadge, et al.. (2025). Immunogenicity and safety of different immunisation schedules of the VLA15 Lyme borreliosis vaccine candidate in adults, adolescents, and children: a randomised, observer-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases. 25(9). 986–999. 4 indexed citations

Kosulin, Karin, Trevor Brasel, Jeanon N. Smith, et al.. (2025). Cross-neutralizing activity of the chikungunya vaccine VLA1553 against three prevalent chikungunya lineages. Emerging Microbes & Infections. 14(1). 2469653–2469653. 1 indexed citations

Wagner, Laura Danielle, Romana Hochreiter, Julian Larcher‐Senn, et al.. (2025). Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in children, adolescents, and adults in the USA: a randomised, observer-blind, placebo-controlled, phase 2 trial. The Lancet Infectious Diseases. 26(3). 314–328. 1 indexed citations

Kreklywich, Craig N., Michael Denton, Luisa I. Alvarado, et al.. (2024). The Approved Live-Attenuated Chikungunya Virus Vaccine (IXCHIQ®) Elicits Cross-Neutralizing Antibody Breadth Extending to Multiple Arthritogenic Alphaviruses Similar to the Antibody Breadth Following Natural Infection. Vaccines. 12(8). 893–893. 16 indexed citations

Chen, Lin H., et al.. (2024). From bench to clinic: the development of VLA1553/IXCHIQ, a live-attenuated chikungunya vaccine. Journal of Travel Medicine. 31(7). 14 indexed citations

Ghadge, Santhosh Kumar, Martina Schneider, Katrin Dubischar, et al.. (2024). Immunogenicity and safety of an 18-month booster dose of the VLA15 Lyme borreliosis vaccine candidate after primary immunisation in healthy adults in the USA: results of the booster phase of a randomised, controlled, phase 2 trial. The Lancet Infectious Diseases. 24(11). 1275–1286. 10 indexed citations

McMahon, Robert P., Martina Schneider, Romana Hochreiter, et al.. (2024). Antibody persistence and safety of a live-attenuated chikungunya virus vaccine up to 2 years after single-dose administration in adults in the USA: a single-arm, multicentre, phase 3b study. The Lancet Infectious Diseases. 24(12). 1383–1392. 15 indexed citations

Wressnigg, Nina, Susanne Eder-Lingelbach, Anders Lilja, et al.. (2023). EFFECTS OF HOMOLOGOUS AND HETEROLOGOUS BOOSTER VACCINATIONS OF THE INACTIVATED DUAL-ADJUVANTED VACCINE VLA2001 AGAINST COVID-19 INCLUDING VARIANTS OF CONCERN: A PHASE 3 RANDOMIZED CLINICAL TRIAL. International Journal of Infectious Diseases. 130. S25–S25. 1 indexed citations

Lazarus, Rajeka, Gerald Maurer, Katrin Dubischar, et al.. (2023). Safety and immunogenicity against ancestral, Delta and Omicron virus variants following a booster dose of an inactivated whole-virus COVID-19 vaccine (VLA2001): Interim analysis of an open-label extension of the randomized, controlled, phase 3 COV-COMPARE trial. Journal of Infection. 87(3). 242–254. 8 indexed citations

10.

Schneider, Martina, Robert P. McMahon, Ulrike Fuchs, et al.. (2023). Safety and immunogenicity of a single-shot live-attenuated chikungunya vaccine: a double-blind, multicentre, randomised, placebo-controlled, phase 3 trial. The Lancet. 401(10394). 2138–2147. 94 indexed citations breakdown →

11.

Hochreiter, Romana, Nina Wressnigg, Julian Larcher‐Senn, et al.. (2023). Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults. The Lancet Infectious Diseases. 23(10). 1186–1196. 23 indexed citations

12.

Roques, Pierre, Nathalie Dereuddre‐Bosquet, Nina Wressnigg, et al.. (2022). Effectiveness of CHIKV vaccine VLA1553 demonstrated by passive transfer of human sera. JCI Insight. 7(14). 47 indexed citations

13.

Westritschnig, Kerstin, Romana Hochreiter, Gerhard Wallner, et al.. (2013). A randomized, placebo-controlled phase I study assessing the safety and immunogenicity of aPseudomonas aeruginosahybrid outer membrane protein OprF/I vaccine (IC43) in healthy volunteers. Human Vaccines & Immunotherapeutics. 10(1). 170–183. 65 indexed citations

14.

Weiss, Richard, Peter Hammerl, Arnulf Hartl, et al.. (2005). Design of Protective and Therapeutic DNA Vaccines for the Treatment of Allergic Diseases. Current Drug Targets - Inflammation & Allergy. 4(5). 585–597. 20 indexed citations

15.

Hartl, Arnulf, Richard Weiss, Romana Hochreiter, Sandra Scheiblhofer, & Josef Thalhamer. (2004). DNA vaccines for allergy treatment. Methods. 32(3). 328–339. 33 indexed citations

16.

Hochreiter, Romana, Fátima Ferreira, Rudolf Valenta, et al.. (2003). Prevention of allergen‐specific IgE production and suppression of an established Th2‐type response by immunization with DNA encoding hypoallergenic allergen derivatives of Bet v 1, the major birch‐pollen allergen. European Journal of Immunology. 33(6). 1667–1676. 42 indexed citations

17.

Hartl, Arnulf, Richard Weiss, Romana Hochreiter, et al.. (2003). Strategies for the development of safe and effective DNA vaccines for allergy treatment.. PubMed. 279–98; discussion 299. 2 indexed citations

18.

Hochreiter, Romana, et al.. (2002). Quantification of histamine in blood plasma and cell culture supernatants: a validated one-step gas chromatography–mass spectrometry method. Analytical Biochemistry. 308(2). 300–306. 24 indexed citations

19.

Hochreiter, Romana, et al.. (2001). The Influence of CpG Motifs on a Protein or DNA-Based Th2-Type Immune Response against Major Pollen Allergens Bet v 1a, Phl p 2 and <i>Escherichia coli</i>-Derived β-Galactosidase. International Archives of Allergy and Immunology. 124(1-3). 406–410. 29 indexed citations

20.

Hochreiter, Romana, Thomas Weiger, Sebastiano Colombatto, et al.. (2000). Long chain diamines inhibit growth of C6 glioma cells according to their hydrophobicity. An in vitro and molecular modeling study. Naunyn-Schmiedeberg s Archives of Pharmacology. 361(3). 235–246. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact